AcouSort AB (publ) (STO:ACOU)

Market Cap	71.96M
Revenue (ttm)	9.69M
Net Income (ttm)	-15.37M
Shares Out	21.16M
EPS (ttm)	-1.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	131
Average Volume	47,853
Open	3.400
Previous Close	3.400
Day's Range	3.400 - 3.400
52-Week Range	3.010 - 20.800
Beta	0.59
RSI	46.66
Earnings Date	May 28, 2025

About AcouSort AB

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrumen...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2010
• Employees: 16
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ACOU

Financial Performance

In 2024, AcouSort AB's revenue was 10.03 million, a decrease of -4.94% compared to the previous year's 10.55 million. Losses were -15.08 million, -11.77% less than in 2023.